Kaletsky RL, Simmons G, Bates P. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity.

J Virol. 2007 Dec;81(24):13378-84.

Simmons G, Rennekamp AJ, Bates P. Proteolysis of SARS-associated coronavirus spike glycoprotein.

Adv Exp Med Biol. 2006;581:235-40.

Chai N, Bates P. Na+/H+ exchanger type 1 is a receptor for pathogenic subgroup J avian leukosis virus.

Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5531-6.

Amberg SM, Netter RC, Simmons G, Bates P. Expanded tropism and altered activation of a retroviral glycoprotein resistant to an entry inhibitor peptide.

J Virol. 2006 Jan;80(1):353-9.

Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.

Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81.

Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion

intermediate.J Virol. 2004 Dec;78(24):13430-9.

Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.

Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4240-5.

Simmons G, Rennekamp AJ, Chai N, Vandenberghe LH, Riley JL, Bates P. Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection.

J Virol. 2003 Dec;77(24):13433-8.

Tanzi GO, Piefer AJ, Bates P. Equine infectious anemia virus utilizes host vesicular protein sorting machinery during particle release.

J Virol. 2003 Aug;77(15):8440-7.

Simmons G, Wool-Lewis RJ, Baribaud F, Netter RC, Bates P. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.

J Virol. 2002 Mar;76(5):2518-28.

Damico R, Bates P. Soluble receptor-induced retroviral infection of receptor-deficient cells.

J Virol. 2000 Jul;74(14):6469-75.

Balliet JW, Gendron K, Bates P. Mutational analysis of the subgroup A avian sarcoma and leukosis virus putative fusion peptide domain.

J Virol. 2000 Apr;74(8):3731-9. P

Damico R, Rong L, Bates P. Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunits.

J Virol.1999 Apr;73(4):3087-94.

Balliet JW, Berson J, D'Cruz CM, Huang J, Crane J, Gilbert JM, Bates P. Production and characterization of a soluble, active form of Tva, the subgroup A  avian sarcoma and leukosis virus receptor.

J Virol. 1999 Apr;73(4):3054-61.

Wool-Lewis RJ, Bates P. Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function.

J Virol. 1999 Feb;73(2):1419-26.

Rong L, Gendron K, Bates P. Conversion of a human low-density lipoprotein receptor ligandbinding repeat to a virus receptor: identification of residues important for ligand specificity.

Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8467-72.

Rong L, Gendron K, Strohl B, Shenoy R, Wool-Lewis RJ, Bates P. Characterization of determinants for envelope binding and infection in tva, the subgroup A avian sarcoma and leukosis virus receptor.

J Virol. 1998 Jun;72(6 :4552-9.

Damico RL, Crane J, Bates P. Receptor-triggered membrane association of a model retroviral glycoprotein.

Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2580-5.

Wool-Lewis RJ, Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.

J Virol. 1998 Apr;72(4):3155-60.  

Balliet JW, Bates P. Efficient infection mediated by viral receptors incorporated into retroviral particles.

J Virol. 1998 Jan;72(1):671-6.